Fam162a, whose specific function is yet to be fully elucidated, has been associated with multiple biological processes. It has been linked to hypoxia-related pathways, lactate metabolism, and glycolysis. These pathways are crucial in various physiological and pathological conditions, such as tumor development, energy metabolism, and response to stress [1,3,4].

Fam162a has been identified in several disease-related gene signatures. In osteosarcoma, it is part of an 8-gene signature related to hypoxia and lactate metabolism, which can predict prognosis, classify "cold" and "hot" tumors, and estimate immunotherapy response [1]. In IDH-mutant glioma, a hypoxia-related survival score including Fam162a can predict patient survival independent of known prognostic factors [3]. In coronary artery disease, it is one of the 4 hub hypoxia-related genes, and is mainly enriched in immune-related biological processes [2]. In colon cancer, it is part of a 13-gene glycolysis-related prognostic prediction model [4]. In addition, it may be related to neuronal apoptosis in chronic cerebral ischemia, as Foxh1 transcriptionally promotes its expression [5].

In conclusion, Fam162a appears to play a significant role in multiple disease conditions, particularly those related to hypoxia, metabolism, and immunity. Findings from various studies suggest its potential as a biomarker or therapeutic target in diseases such as osteosarcoma, glioma, coronary artery disease, and colon cancer. Research on Fam162a provides insights into the underlying mechanisms of these diseases and may offer new directions for treatment strategies.

References:

1. Wang, Yizhuo, Wang, Xin, Liu, Yang, Zheng, Yufu, Qi, Quan. 2024. A novel hypoxia- and lactate metabolism-related prognostic signature to characterize the immune landscape and predict immunotherapy response in osteosarcoma. In Frontiers in immunology, 15, 1467052. doi:10.3389/fimmu.2024.1467052. https://pubmed.ncbi.nlm.nih.gov/39569192/

2. Jin, Yuqing, Ren, Weiyan, Liu, Jiayi, Hou, Lianguo, Yang, Lei. 2023. Identification and validation of potential hypoxia-related genes associated with coronary artery disease. In Frontiers in physiology, 14, 1181510. doi:10.3389/fphys.2023.1181510. https://pubmed.ncbi.nlm.nih.gov/37637145/

3. Dao Trong, Philip, Rösch, Saskia, Mairbäurl, Heimo, Herold-Mende, Christel, Warta, Rolf. 2018. Identification of a Prognostic Hypoxia-Associated Gene Set in IDH-Mutant Glioma. In International journal of molecular sciences, 19, . doi:10.3390/ijms19102903. https://pubmed.ncbi.nlm.nih.gov/30257451/

4. Liu, Gang, Wu, Xiaoyang, Chen, Jian. 2022. Identification and validation of a glycolysis-related gene signature for depicting clinical characteristics and its relationship with tumor immunity in patients with colon cancer. In Aging, 14, 8700-8718. doi:10.18632/aging.204226. https://pubmed.ncbi.nlm.nih.gov/35963622/

5. Yang, Jin, Liu, Xiaobai, Zhao, Yubo, Cui, Zheng, Liu, Yunhui. 2023. Mechanism of Dcp2/RNCR3/Dkc1/Snora62 axis regulating neuronal apoptosis in chronic cerebral ischemia. In Cell biology and toxicology, 39, 2881-2898. doi:10.1007/s10565-023-09807-8. https://pubmed.ncbi.nlm.nih.gov/37097350/